Publications by authors named "Reid Bissonnette"

Claim this Profile
T
The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.
Reid P Bissonnette, Rosemary M Cesario, Bob Goodenow, Farbod Shojaei, Mireille Gillings

BMC Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of apoptosis by HBI-8000 in adult T-cell leukemia/lymphoma is associated with activation of Bim and NLRP3.
Hiroo Hasegawa, Reid P Bissonnette, Mireille Gillings, Daisuke Sasaki, Hiroaki Taniguchi

Cancer Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.
Abhijit Mazumdar, Daniel Medina, Francis S Kittrell, Yun Zhang, Jamal L Hill, Reid P Bissonnette

Cancer Prev Res (Phila)· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.
Iván P Uray, Jennifer M Rodenberg, Reid P Bissonnette, Powel H Brown, Michael A Mancini

Mol Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor.
Yuxin Li, Qiang Shen, Hee-Tae Kim, Reid P Bissonnette, William W Lamph

Breast Cancer Res Treat· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination PPARgamma and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2.
Joshua P Klopper, Vibha Sharma, Reid Bissonnette, Bryan R Haugen

PPAR Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.
Martín C Abba, Yuhui Hu, Carla C Levy, Sally Gaddis, Frances S Kittrell, Reid P Bissonnette

Cancer Prev Res (Phila)· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.
Iván P Uray, Qiang Shen, Hye-Sook Seo, HeeTae Kim, William W Lamph, Reid P Bissonnette

J Biol Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.
Martin C Abba, Yuhui Hu, Carla C Levy, Sally Gaddis, Frances S Kittrell, Reid P Bissonnette

BMC Med Genomics· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G0S2 is an all-trans-retinoic acid target gene.
Sutisak Kitareewan, Steven Blumen, David Sekula, Reid P Bissonnette, William W Lamph

Int J Oncol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
Powel H Brown, Kotha Subbaramaiah, Amoi P Salmon, Rebecca Baker, Robert A Newman, Reid P Bissonnette

Cancer Prev Res (Phila)· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma.
Joshua P Klopper, Andrew Berenz, William R Hays, Vibha Sharma, Umarani Pugazhenthi, Reid P Bissonnette

Clin Cancer Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor negative tumors in MMTV-erbB2 mice.
Yuxin Li, Yun Zhang, Jamal Hill, Qiang Shen, Hee-Tae Kim, Reid P Bissonnette

Clin Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
Andrew R Hudson, Steven L Roach, Robert I Higuchi, Dean P Phillips, Reid P Bissonnette

J Med Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
Hee-Tae Kim, Gu Kong, David Denardo, Yuxin Li, Ivan Uray, Reid Bissonnette

Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Rosemary M Cesario, Jessica Stone, Wan-Ching Yen, Reid P Bissonnette, William W Lamph

Cancer Lett· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.
Kendall Wu, Elizabeth DuPré, Heetae Kim, Caesar K Tin-U, Reid P Bissonnette

Breast Cancer Res Treat· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
Thomas W Hermann, Wan-Ching Yen, Patricia Tooker, Bingqi Fan, Karen Roegner, Reid P Bissonnette

Lung Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
Gu Kong, Hee-Tae Kim, Kendall Wu, David DeNardo, Susan G Hilsenbeck, Reid Bissonnette

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinoid-induced mu opioid receptor expression by phytohemagglutinin-stimulated U937 cells.
Walter Royal, Michelle V Leander, Reid Bissonnette

J Neurovirol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear receptor activation and interaction with morphine.
Walter Royal, Michelle Leander, Yuqing E Chen, Eugene O Major, Reid P Bissonnette

J Neuroimmunol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective retinoid X receptor agonist bexarotene (Targretin) prevents and overcomes acquired paclitaxel (Taxol) resistance in human non-small cell lung cancer.
Wan-Ching Yen, Manny R Corpuz, Rene Y Prudente, Tracy A Cooke, Reid P Bissonnette

Clin Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RXR-induced TNF-alpha suppression is reversed by morphine in activated U937 cells.
Liping Mou, Pamela Lankford-Turner, Michelle V Leander, Reid P Bissonnette, Robert M Donahoe

J Neuroimmunol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis